Product Alert for Oxycodone Sandoz 5mg Modified Release Tablets

HPS Pharmacies wish to give notice that Sandoz, in consultation with the Therapeutic Goods Administration (TGA), has issued a product alert for Oxycodone Sandoz Modified Release Tablets as follows:

Oxycodone Sandoz Modified Release Tablets
Oxycodone hydrochloride 5 mg
ARTG 153605

This product alert was initiated following reports that a batch of modified release tablets was supplied without the ‘modified release’ text on the blister pack. This may cause confusion between other forms of oxycodone tablets and lead to medication errors. The outer carton correctly describes the dosage form as modified release.

The only batch affected by this notice is: PS9028 (Expiry: Feb 2028)

Actions recommended by Sandoz:

• Reassure patients that the product is modified release as described in the outer packaging.
• Store medications in their original packaging.

Sandoz advises that product with the corrected blister packaging will be available from September 2026.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Sandoz at 1800 726 369 or your pharmacist at HPS Pharmacies.

Download PDF